The University of Bristol is offering a fully funded PhD project focused on developing targeted covalent macrocycles (TCMs) as pathway-specific inhibitors of the complement system, with potential applications in inflammatory and autoimmune diseases.
The project will combine phage display, peptide chemistry, molecular biology, biophysical analysis, structural biology, proteomics, and bioinformatics to develop selective inhibitors targeting C1s and factor D.
#J-18808-Ljbffr
Phage Display PhD: Covalent Inhibitors for Complement employer: The Phage
The University of Salford offers an exceptional opportunity for aspiring researchers in the field of bacteriophage therapy, providing a collaborative environment with leading institutions like the University of Liverpool and the University of Limerick. With a strong focus on advancing oral health through innovative research, the university fosters a supportive work culture that encourages professional growth and development, while also contributing to meaningful solutions for global health challenges. This PhD position not only allows for hands-on laboratory experience but also promotes collaboration across disciplines, making it an ideal setting for those passionate about tackling antimicrobial resistance.
